132 related articles for article (PubMed ID: 26743834)
1. Medically inoperable endometrial cancer in patients with a high body mass index (BMI): Patterns of failure after 3-D image-based high dose rate (HDR) brachytherapy.
Acharya S; Esthappan J; Badiyan S; DeWees TA; Tanderup K; Schwarz JK; Grigsby PW
Radiother Oncol; 2016 Jan; 118(1):167-72. PubMed ID: 26743834
[TBL] [Abstract][Full Text] [Related]
2. Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.
Kauffmann G; Wu T; Al-Hallaq H; Hasan Y
Brachytherapy; 2017; 16(1):141-146. PubMed ID: 27866953
[TBL] [Abstract][Full Text] [Related]
3. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification.
Vargo JA; Kim H; Houser CJ; Berhane H; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
Radiother Oncol; 2014 Oct; 113(1):126-31. PubMed ID: 25241996
[TBL] [Abstract][Full Text] [Related]
4. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
5. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma.
Jordan SE; Micaily I; Hernandez E; Ferriss JS; Miyamoto CT; Li S; Micaily B
Brachytherapy; 2017; 16(6):1144-1151. PubMed ID: 28958736
[TBL] [Abstract][Full Text] [Related]
6. Implementation of image-guided brachytherapy as part of non-surgical treatment in inoperable endometrial cancer patients.
Espenel S; Kissel M; Garcia MA; Schernberg A; Gouy S; Bockel S; Limkin E; Fabiano E; Meillan N; Magné N; Leary A; Pautier P; Morice P; Fumagalli I; Haie-Meder C; Chargari C
Gynecol Oncol; 2020 Aug; 158(2):323-330. PubMed ID: 32475773
[TBL] [Abstract][Full Text] [Related]
7. High-dose-rate brachytherapy for medically inoperable stage I endometrial cancer.
Nguyen TV; Petereit DG
Gynecol Oncol; 1998 Nov; 71(2):196-203. PubMed ID: 9826460
[TBL] [Abstract][Full Text] [Related]
8. Image-guided high-dose-rate brachytherapy as the method of choice in medically inoperable early-stage endometrial cancer patients.
Rydzinski M; Bijok M; Michalski W; Kowalczyk A; Gruszczynska E; Zolciak-Siwinska A
Gynecol Oncol; 2024 Jan; 180():6-13. PubMed ID: 38035868
[TBL] [Abstract][Full Text] [Related]
9. Image-based three-dimensional conformal brachytherapy for medically inoperable endometrial carcinoma.
Gill BS; Kim H; Houser C; Olsen A; Kelley J; Edwards RP; Comerci J; Sukumvanich P; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
Brachytherapy; 2014; 13(6):542-7. PubMed ID: 25127122
[TBL] [Abstract][Full Text] [Related]
10. Image-guided tandem and cylinder brachytherapy as monotherapy for definitive treatment of inoperable endometrial carcinoma.
Gebhardt B; Gill B; Glaser S; Kim H; Houser C; Kelley J; Sukumvanich P; Edwards R; Comerci J; Olawaiye A; Courtney-Brooks M; Boisen M; Berger J; Beriwal S
Gynecol Oncol; 2017 Nov; 147(2):302-308. PubMed ID: 28923412
[TBL] [Abstract][Full Text] [Related]
11. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
12. Image-guided brachytherapy following external-beam radiation therapy for patients with inoperable endometrial cancer.
Huang CH; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY; Chen SW
Brachytherapy; 2023; 22(1):72-79. PubMed ID: 36244907
[TBL] [Abstract][Full Text] [Related]
13. Management of elderly patients with early-stage medically inoperable endometrial cancer: Systematic review and National Cancer Database analysis.
Dutta SW; Trifiletti DM; Grover S; Boimel P; Showalter TN
Brachytherapy; 2017; 16(3):526-533. PubMed ID: 28262518
[TBL] [Abstract][Full Text] [Related]
14. Upfront radiotherapy with brachytherapy for medically inoperable and unresectable patients with high-risk endometrial cancer.
Gannavarapu BS; Hrycushko B; Jia X; Albuquerque K
Brachytherapy; 2020; 19(2):139-145. PubMed ID: 32061534
[TBL] [Abstract][Full Text] [Related]
15. High-dose-rate Rotte "Y" applicator brachytherapy for definitive treatment of medically inoperable endometrial cancer: 10-year results.
Coon D; Beriwal S; Heron DE; Kelley JL; Edwards RP; Sukumvanich P; Zorn KK; Krivak TC
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):779-83. PubMed ID: 18258388
[TBL] [Abstract][Full Text] [Related]
16. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
Fusco V; Troiano M; Corsa P; Raguso A; Lioce M; Lauriola P; Parisi S
Radiol Med; 1998 Jun; 95(6):640-6. PubMed ID: 9717549
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of high-dose-rate brachytherapy and external-beam radiotherapy in the primary treatment of endometrial cancer.
Inciura A; Atkocius V; Juozaityte E; Vaitkiene D
J Radiat Res; 2010; 51(6):675-81. PubMed ID: 21116100
[TBL] [Abstract][Full Text] [Related]
18. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
19. Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1-2, stage IC endometrial cancer.
Cengiz M; Singh AK; Grigsby PW
Int J Gynecol Cancer; 2005; 15(5):926-31. PubMed ID: 16174247
[TBL] [Abstract][Full Text] [Related]
20. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
